Radiotherapy combined with the immunocytokine (L19-IL2) provides long-lasting anti-tumor effects

Zegers, Catharina M.L.; Rekers, Nicolle H.; Quaden, Dana H.F.; Lieuwes, Natasja G.; Yaromina, Ala; Germeraad, Wilfred T.V.; Wieten, Lotte; Biessen, Erik A.L.; Boon, Louis; Neri, Dario; Troost, Esther G.C.; Dubois, Ludwig J.; Lambin, Philippe

doi:10.1158/1078-0432.CCR-14-2676

Metadata only

Author

Zegers, Catharina M.L.

Germeraad, Wilfred T.V.

Date

2015-03

Type

Journal Article

Citations

Cited 86 times in Scopus

ETH Bibliography

yes

Altmetrics

Publication status

published

External links

https://doi.org/10.1158/1078-0432.CCR-14-2676

Journal / series

Clinical Cancer Research

Volume

21

Pages / Article No.

1151 - 1161

Publisher

American Association for Cancer Research

Organisational unit

03463 - Neri, Dario (ehemalig) / Neri, Dario (former)

Notes

Published online 31 December 2014.

More

Show all metadata

Citations

Cited 86 times in Scopus

ETH Bibliography

yes

Altmetrics

Research Collection

Search

Radiotherapy combined with the immunocytokine (L19-IL2) provides long-lasting anti-tumor effects Mendeley CSV RIS BibTeX

Radiotherapy combined with the immunocytokine (L19-IL2) provides long-lasting anti-tumor effects

Mendeley

CSV

RIS

BibTeX